Verification register Bio, Health & Neuro
Current reading
Readiness band and full integer triple
AI-assisted assembly · derived results
Readiness band
Watch
Primary summary from verified readiness
- Confidence
- 70% · stale
- Computed at
- 2026-09-22T23:27:14.984527+00:00
- Claimed
- 78
- Reported
- 68
- Verified
- 58
- Gap
- +20
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed leads verified
Evidence strength Strong
Decision
What the current evidence supports
Human editorial judgment · 2026-09-22
Proceed with caution
- Why
- Genuinely the most mature sa-RNA technology - approved in Japan and the EU with superior 12-month antibody durability vs conventional mRNA - but a US regulatory block and weak real-world uptake mean the platform is approved yet not de-risked for broad deployment.
- Next
- Track real-world effectiveness/durability data and whether the FDA clinical-endpoint requirement is met; monitor EU/Japan uptake as the true adoption signal
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 6
- Tier 1
- 4
- Tier 2
- 2
- Tier 3
- 0
- Supports
- 3
- Contradicts
- 3
- Context
- 0
- Latest observed
- 2025-10-14
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Revision 2
- 2026-07-19 Reading moved from watch to watch.
- 2026-09-22 Reading moved from watch to watch.